Europe Antimicrobial Susceptibility Testing Market (2024-2029)
The Europe Antimicrobial Susceptibility Testing Market was valued at $1212.7 Million in 2024 and projected to reach to $1471 Million by 2029, representing a compound annual growth rate of CAGR 3.9%. Europe's antimicrobial susceptibility testing market is positioned for steady growth, driven by regulatory mandates on antimicrobial stewardship and increasing clinical demand for rapid pathogen identification.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Europe Antimicrobial Susceptibility Testing Market Trends and Insights
- In Europe, the market is driven by stringent regulatory frameworks, rising antimicrobial resistance concerns, and advanced healthcare infrastructure across member states.
- Europe's commitment to combating antibiotic resistance through initiatives like the European Antimicrobial Resistance Surveillance System (EARS-Net) continues to propel demand for accurate susceptibility testing solutions.
- The region's established diagnostic laboratory networks and high adoption of automated testing platforms position Europe as a mature yet steadily growing market through 2029..
Key Market Statistics
- CAGR (2024-2029) CAGR 3.9%
- Market Size, 2024 ~USD 1212.7 Million
- Forecast, 2029 ~USD 1471 Million
- Geography Europe
Europe Antimicrobial Susceptibility Testing Market Overview
Regulatory Leadership :
Europe's stringent regulatory frameworks, including EU antimicrobial resistance directives and stewardship programs, drive consistent adoption of advanced susceptibility testing across member states.
Rising AMR Burden :
Increasing antimicrobial resistance prevalence across European healthcare systems necessitates rapid, accurate susceptibility testing to guide targeted antibiotic therapy and infection control measures.
Advanced Healthcare Infrastructure :
Well-established laboratory networks and high healthcare spending across Europe enable widespread deployment of automated and molecular-based susceptibility testing platforms.
Market Consolidation :
Germany, France, and the UK represent 60% of Europe's market value, reflecting concentrated diagnostic capabilities and healthcare investment in Western European nations.
Europe Antimicrobial Susceptibility Testing Market Dynamics
- The region's mature healthcare infrastructure and high diagnostic adoption rates support consistent market expansion at 3.9% CAGR through 2029.
- Investment in next-generation sequencing and automated platforms will enhance testing accuracy and turnaround times across European laboratories. Key growth catalysts include EU-wide antimicrobial resistance surveillance initiatives, hospital accreditation requirements, and rising prevalence of multidrug-resistant organisms.
- However, market growth remains moderate compared to global rates due to market saturation in developed economies and budget constraints in some member states.
- Strategic partnerships between diagnostic manufacturers and European healthcare systems will be critical for capturing emerging opportunities in point-of-care and molecular testing segments..
Related Ecosystem
Healthcare It
- Computed Tomography (CT)
- Machine Learning
- Magnetic Resonance Imaging (MRI)
- Natural Language Processing (NLP)
- Predictive Analytics
- CERNER CORPORATION
- PHILIPS HEALTHCARE
- Oracle Corporation
- GE HealthCare Technologies Inc.
- Siemens healthineers
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- Europe's antimicrobial susceptibility testing market is valued at $1,212.7 million in 2024 and will reach $1,471.0 million by 2029.
- Europe maintains a 3.9% CAGR, reflecting steady growth driven by regulatory compliance and antimicrobial resistance surveillance initiatives.
- Europe's mature healthcare infrastructure and automated laboratory systems support consistent market expansion through the forecast period.
- Europe's stringent EU regulations and public health policies create sustained demand for advanced susceptibility testing technologies.
Antimicrobial Susceptibility Testing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | LAB INSTRUMENTS (Product) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 5% from 2024 to 2029 |
| Largest Segment | QUALITATIVE METHODS (Method) |
| Market Size Base Year (Billions) | ~USD 4.45 (2024) |
| Revenue Forecast (Billions) | ~USD 5.68 (2029) |
| Segments Covered | Product, Type, Method, Application, End User |
Europe Antimicrobial Susceptibility Testing Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Consumables
- Lab Disposables
- Lab Instruments
By Type
- Agar Dilution
- Antibacterial Susceptibility Testing
- Antifungal Susceptibility Testing
- Antiparasitic Susceptibility Testing
- Antiviral Susceptibility Testing
- Automated Ast
- Automated Laboratory Instruments
- Broth Macrodilution
- Culture & Growth Media
- Culture And Growth Media
- Disk Diffusion
- Etest Method
- Genotypic Method
- Mic Strips
- Molecular Diagnostics Systems
- Susceptibility Plates
- Susceptibility Testing Disks
By Method
- Qualitative Methods
- Quantitative Methods
By Application
- Clinical Diagnostics
- Drug Discovery & Development
- Epidemiology
- Other Applications
By End User
- Academic & Research Institutes
- Cros
- Hospitals & Diagnostic Centers
- Pharmaceutical & Biotechnology Companies
EUROPE: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2022–2029
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 123.5 | 124.8 | 128 | 131.6 | 135.6 | 140.1 | 146.8 | 154.4 | 3.8 |
| CROS | 45.3 | 45.4 | 46.2 | 47.2 | 48.3 | 49.5 | 51.5 | 53.7 | 3.1 |
| HOSPITALS & DIAGNOSTIC CENTERS | 764.4 | 773 | 792.5 | 814.8 | 838.6 | 865.5 | 910.1 | 960.8 | 3.9 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 235.7 | 239.1 | 246.1 | 254 | 262.6 | 272.3 | 286.3 | 302.1 | 4.2 |
| TOTAL | 1168.8 | 1182.4 | 1212.7 | 1247.7 | 1285.1 | 1327.5 | 1394.7 | 1471 | 3.9 |
Target Audience
- In Vitro Diagnostic Manufacturers : Develop and commercialize AST platforms tailored to European regulatory requirements and hospital workflows to capture market share in this $1.2B+ region.
- Clinical Laboratory Directors : Evaluate AST technology investments and supplier partnerships to improve diagnostic accuracy, reduce turnaround times, and support antimicrobial stewardship initiatives.
- Hospital Procurement Teams : Make informed purchasing decisions on AST instruments and consumables by understanding market trends, competitive offerings, and total cost of ownership across European healthcare systems.
- Healthcare Policy Makers : Design antimicrobial resistance surveillance programs and stewardship policies informed by market data on AST adoption, technology gaps, and regional healthcare infrastructure.
- Investment & Consulting Firms : Assess market opportunities, competitive dynamics, and growth drivers in Europe's AST sector to guide M&A strategies, portfolio investments, and strategic advisory engagements.
Countries within Europe - compare and drill down
| Country | 2025 size (native) |
|---|---|
| Germany | USD 418.9 Million |
| France | USD 317.4 Million |
| UK | USD 246.5 Million |
| Italy | USD 134.5 Million |
| Spain | USD 92.8 Million |
| Rest Of Europe | USD 260.9 Million |
Country market size visualization
Reasons to Buy this Report
- Country-Level Market Segmentation : Access detailed market sizing for Germany, France, UK, Italy, Spain, and Rest of Europe to identify high-growth regions and prioritize market entry strategies.
- Regulatory Landscape Insights : Understand EU antimicrobial stewardship directives, ISO standards, and member-state compliance requirements shaping procurement and adoption decisions across European laboratories.
- Competitive Positioning : Benchmark your portfolio against regional competitors and identify market gaps in automated, molecular, and point-of-care susceptibility testing segments across Europe.
- Growth Forecasting : Leverage 5-year projections (2024-2029) to forecast revenue potential, allocate R&D resources, and plan commercial expansion in Europe's $1.47 billion market by 2029.
- Strategic Partnership Opportunities : Identify high-value collaboration targets among European hospital networks, reference laboratories, and diagnostic distributors to accelerate market penetration.
Frequently asked questions
What is the current size of Europe's antimicrobial susceptibility testing market?
Europe's antimicrobial susceptibility testing market was valued at $1,212.7 million in 2024.
What is the projected market size for Europe by 2029?
Europe's antimicrobial susceptibility testing market is projected to reach $1,471.0 million by 2029.
What is the CAGR for Europe's antimicrobial susceptibility testing market?
Europe's market is expected to grow at a compound annual growth rate of 3.9% from 2024 to 2029.
What factors are driving growth in Europe's antimicrobial susceptibility testing market?
Growth in Europe is driven by stringent regulatory frameworks, rising antimicrobial resistance concerns, advanced healthcare infrastructure, and EU surveillance initiatives like EARS-Net.
How does Europe's market growth compare to global trends?
Europe's 3.9% CAGR is slightly lower than the global 5% CAGR, reflecting a more mature and regulated market with steady, sustainable expansion.
RESEARCH METHODOLOGY
In that respect, the research has heavily employed both primary and secondary sources in order to comprehensively study the forces influential in the industry. This methodology comprised market segmentation analysis, industry trends, major players, competitive landscape, key market dynamics, and strategies of key companies.
Secondary Research
The secondary research involves D&B Hoovers, Bloomberg Businessweek, Factiva, white papers, annual reports, company filings, investor presentations, and SEC filings for conducting secondary research in developing a database on major industry participants. Key data with regard to leading players, market segmentation, at a various level, industry trends by segments, significant mergers and acquisitions, and the impact of trends and technological perspectives related to the antimicrobial susceptibility testing market.
Primary Research
Primary research in the report included interviewing a cross-section, both from the demand and supply sides, to capture information qualitatively and quantitatively. Supply side: High-level executives' interviews, such as CEOs, VPs, marketing and sales directors, regional sales managers, and technology and innovation directors were contacted from leading companies and organizations in product therapy markets. On the demand side, research was carried out by discussing with professionals like clinicians, procurement managers, purchase managers, department heads, and experts from hospitals, diagnostic centers, pharmaceutical and biotechnological firms, and research and academic institutes. This was necessary to gain a proper view of the market segmentation, significant players in the market, and key trends and dynamics related to the growth of the market.
A breakdown of the primary respondents is provided below:
*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1 billion, Tier 2 = < USD 500 million, and Tier 3 = < USD 100 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
This research examines the Antimicrobial Susceptibility testing market and revenue share among the market leaders. It made use of a combination of primary and secondary research methods to do so. Primary research involved in-depth interviews with CEOs, directors, and senior marketing executives. Secondary research formed annual and financial reports by major industry players. The market value was determined while following a segment-based strategy, and it used revenue details of leading solution providers for differentiating between sources and services.
Covered segments:
Identify the major companies involved in the world Antimicrobial Susceptibility testing market and document their annual revenues or revenues from their particular product category/business division.
The revenue mapping of these leading competitors, based on 2024 data, captures a good share of the market and is thus extrapolated to estimate the total global value of the Antimicrobial Susceptibility testing market:
Data Triangulation
Based on the methodology, categorical and sub-categories segmentation of the global antimicrobial susceptibility testing market was performed. Further, data triangulation and the segmentation process were undertaken to arrive at an accurate data of different segments for the market. Various analyses involved factors and trends of the demand and supply sides. The integration of detailed top-down and bottom-up approaches offered a holistic overview of the antimicrobial susceptibility testing market
Market Definition
The Antimicrobial Susceptibility Testing market involves the diagnosis and determination of effectiveness against pathogens such as bacteria, fungi, and viruses using antimicrobial agents. It consists of several technologies and methodologies employed for the diagnosis of the susceptibility of microorganisms to a variety of antimicrobial agents through automated systems, molecular diagnostics, and traditional culture-based methods. The main aim of AST is to be able to choose appropriate therapy, enhance patient outcomes, and take against the threat of emerging antimicrobial resistance. The market includes products and services used by clinical laboratories, hospitals, research institutions, and other healthcare facilities.
Stakeholders
- Healthcare institutions (hospitals and clinics)
- Healthcare institutions (hospitals and diagnostic centers)
- Research institutions
- Clinical research organizations
- Academic medical centers and universities
- Reference laboratories
- Accountable Care Organizations (ACOs)
- Research and consulting firms
- Contract research organizations (CROs) and contract manufacturing organizations (CMOs)
- Academic medical centers and universities
- Market research and consulting firms
- Group Purchasing Organizations (GPOs)
- Medical Research Laboratories
- Academic Medical Centers and Universities
Report Objectives
- Define, describe, and project the antimicrobial susceptibility testing (AST) market across various dimensions, including product, type, methods, applications, end users, and regional areas.
- Explore opportunities for stakeholders and provide a detailed analysis of the competitive landscape, highlighting the key players in the market.
- Offer comprehensive insights into the principal factors influencing market growth.
- Analyze micro markets by evaluating individual growth trends, potential, and their contributions to the overall market.
- Monitor and review competitive developments such as new product launches, approvals, agreements, partnerships, expansions, acquisitions, and collaborations in the AST sector.
Get the Full Antimicrobial Susceptibility Testing Market Report
Full forecast, segment splits, and company analysis for all Antimicrobial Susceptibility Testing Market.
- Canada Antimicrobial Susceptibility Testing Market
- US Antimicrobial Susceptibility Testing Market
- Germany Antimicrobial Susceptibility Testing Market
- France Antimicrobial Susceptibility Testing Market
- UK Antimicrobial Susceptibility Testing Market
- Italy Antimicrobial Susceptibility Testing Market
- Spain Antimicrobial Susceptibility Testing Market
- Japan Antimicrobial Susceptibility Testing Market
- China Antimicrobial Susceptibility Testing Market
- India Antimicrobial Susceptibility Testing Market
- Australia Antimicrobial Susceptibility Testing Market
- South Korea Antimicrobial Susceptibility Testing Market
- Brazil Antimicrobial Susceptibility Testing Market
- Mexico Antimicrobial Susceptibility Testing Market
- Rest Of Europe Antimicrobial Susceptibility Testing Market
- Rest Of Asia Pacific Antimicrobial Susceptibility Testing Market
- Rest Of Latin America Antimicrobial Susceptibility Testing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
